Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman Successfully Represents Modular Medical, Inc. Close $15 Million Public Offering and Nasdaq Uplisting

Lucosky Brookman Successfully Represents Modular Medical, Inc. Close $15 Million Public Offering and Nasdaq Uplisting

Lucosky Brookman LLP congratulates its client, Modular Medical, Inc. (NASDAQ: MODD), a development-stage insulin pump company focused on…

Read More
Lucosky Brookman LLP Successfully Represents EF Hutton in $16.3 Million Initial Public Offering and Nasdaq Listing of TC Biopharm

Lucosky Brookman LLP Successfully Represents EF Hutton in $16.3 Million Initial Public Offering and Nasdaq Listing of TC Biopharm

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $16.3 million initial public…

Read More
Lucosky Brookman Successfully Represents American Rebel Holdings, Inc. in Pricing of $10.5 Million Public Offering and Nasdaq Listing

Lucosky Brookman Successfully Represents American Rebel Holdings, Inc. in Pricing of $10.5 Million Public Offering and Nasdaq Listing

Lucosky Brookman LLP congratulates its client, American Rebel Holdings, Inc. (NASDAQ: AREB; AREBW), a designer and marketer of branded safes…

Read More
Lucosky Brookman Successfully Represents BiondVax Pharmaceuticals Ltd. in Closing of $9.8 million Follow-on Underwritten Offering of ADSs

Lucosky Brookman Successfully Represents BiondVax Pharmaceuticals Ltd. in Closing of $9.8 million Follow-on Underwritten Offering of ADSs

Lucosky Brookman LLP congratulates its client, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) on its successful closing of an underwritten…

Read More
Lucosky Brookman Successfully Represents EF Hutton in $8.0 Million Public Offering of Applied UV, Inc.

Lucosky Brookman Successfully Represents EF Hutton in $8.0 Million Public Offering of Applied UV, Inc.

Lucosky Brookman congratulates its client, EF Hutton on its successful public offering of $8.0 million of common stock of Applied UV, Inc.…

Read More
Lucosky Brookman LLP Successfully Represents EF Hutton in $287.5 Million Initial Public Offering of BurTech Acquisition Corp. Common Stock

Lucosky Brookman LLP Successfully Represents EF Hutton in $287.5 Million Initial Public Offering of BurTech Acquisition Corp. Common Stock

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $287.5 million initial public…

Read More
Lucosky Brookman LLP Successfully Represents Australian Company, Advanced Human Imaging Limited, in a $10.5 Million Initial Public Offering of American Depositary Shares (ADS)

Lucosky Brookman LLP Successfully Represents Australian Company, Advanced Human Imaging Limited, in a $10.5 Million Initial Public Offering of American Depositary Shares (ADS)

Lucosky Brookman LLP congratulates its Australian client, Advanced Human Imaging Limited (ASX:AHI) (NASDAQ: AHI) on its successful closing of its…

Read More
GreenBox POS Announces $100 Million Indenture Financing

GreenBox POS Announces $100 Million Indenture Financing

Lucosky Brookman LLP is pleased to share that its client GreenBox POS (Nasdaq: GBOX) (the “Company”), an emerging fintech company that…

Read More
Lucosky Brookman LLP Successfully Represents EF Hutton in $100 Million Initial Public Offering of Energem Corp. Preferred Stock

Lucosky Brookman LLP Successfully Represents EF Hutton in $100 Million Initial Public Offering of Energem Corp. Preferred Stock

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $100 million initial public…

Read More
Lucosky Brookman LLP Successfully Represents HeartBeam, Inc. in $16.5 Million Initial Public Offering

Lucosky Brookman LLP Successfully Represents HeartBeam, Inc. in $16.5 Million Initial Public Offering

Lucosky Brookman LLP congratulates its client, Heartbeam, Inc. (Nasdaq: BEAT), a developmental stage digital healthcare company with a proprietary…

Read More